Stockscreener 앱 받기
1.34
3.88%
0.05
시장 영업 전:
1.34
전일 마감가:
$1.29
열려 있는:
$1.28
하루 거래량:
491.75K
Relative Volume:
0.39
시가총액:
$175.67M
수익:
$4.35M
순이익/손실:
$-45.53M
주가수익비율:
-1.2407
EPS:
-1.08
순현금흐름:
$-44.79M
1주 성능:
+11.67%
1개월 성능:
+10.74%
6개월 성능:
+31.37%
1년 성능:
-15.72%
1일 변동 폭
$1.28
$1.35
1주일 범위
$1.18
$1.35
52주 변동 폭
$0.9495
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
명칭
Lucid Diagnostics Inc
전화
212 949 4319
주소
360 MADISON AVENUE, NEW YORK
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.34 | 169.12M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 개시 | BTIG Research | Buy |
| 2021-11-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 개시 | Needham | Buy |
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
What’s the fair value of Lucid Diagnostics Inc. stock2025 Winners & Losers & Low Risk High Reward Ideas - mfd.ru
Surprises Report: Can Lucid Diagnostics Inc be recession proofWeekly Trade Review & Precise Trade Entry Recommendations - baoquankhu1.vn
Will Lucid Diagnostics Inc. stock remain a Wall Street favoriteQuarterly Market Summary & AI Powered Buy/Sell Recommendations - mfd.ru
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Update - MarketBeat
Can Lucid Diagnostics Inc. lead its sector in growthWeekly Loss Report & Safe Entry Point Identification - mfd.ru
Earnings Miss: Is Lucid Diagnostics Inc showing insider buying2025 Volume Leaders & Weekly Watchlist of Top Performers - baoquankhu1.vn
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed wipes out legacy convertibles in $45M balance-sheet reset - Stock Titan
Stock Analysis: What is Lucid Diagnostics Incs valuation compared to sector2025 Growth vs Value & Daily Chart Pattern Signals - baoquankhu1.vn
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Down 20.0% in January - MarketBeat
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Is Lucid Diagnostics Inc. gaining market share2025 Technical Overview & Fast Exit and Entry Strategy Plans - mfd.ru
Revenue Check: Is Corvus Pharmaceuticals Inc a stock for growth or value investorsWeekly Profit Summary & AI Based Buy and Sell Signals - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD) - Seeking Alpha
Perkins Capital Management Inc. Invests $1.14 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
PAVmed subsidiary Lucid Diagnostics spikes on Veterans Affairs contract - MSN
Individual investors among Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest stockholders and were hit after last week's 14% price drop - simplywall.st
Retail Surge: Can Lucid Diagnostics Inc expand into new markets2025 Institutional Moves & Stock Timing and Entry Methods - baoquankhu1.vn
Aug Summary: Can Lucid Diagnostics Inc expand into new marketsMarket Growth Review & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
What's Going On With PAVmed Shares Thursday? - Benzinga
Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - MEXC
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares - TechStock²
Lucid Diagnostics secures VA contract for esophageal cancer test By Investing.com - Investing.com Nigeria
Lucid Diagnostics Inc. (LUCD) stock: slides after early spike despite major VA contract win - parameter.io
PAVmed Inc. Stock (PAVM) Opinions on VA Contract Win - Quiver Quantitative
PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs? - Stocktwits
Why Is PAVmed Stock Skyrocketing Wednesday? - Benzinga
PAVM stock shot up over 250% today – what’s the deal with the Department of Veterans Affairs? - MSN
Lucid Diagnostics Wins U.S. Department of Veterans Affairs Contract for EsoGuard - marketscreener.com
Lucid Diagnostics stock surges after securing VA contract for cancer test - Investing.com Australia
Lucid Diagnostics stock surges after securing VA contract for cancer test By Investing.com - Investing.com South Africa
PAVmed-unit Lucid Diagnostics spikes on VA contract (LUCD) - Seeking Alpha
Lucid Diagnostics rises after winning VA contract for cancer test - TradingView
Lucid Diagnostics secures VA contract for esophageal cancer test - Investing.com
Aug Gainers: Is Lucid Diagnostics Inc stock a top performer YTD2025 Market Trends & Low Risk Growth Stock Ideas - baoquankhu1.vn
Forecast Cut: Is Lucid Diagnostics Inc gaining market share2025 Earnings Impact & Real-Time Volume Analysis - baoquankhu1.vn
Why Lucid Diagnostics Inc. stock remains on buy listsWeekly Risk Report & Consistent Profit Trade Alerts - ulpravda.ru
Lucid Diagnostics Insider Ups Holding By 162% During Year - Yahoo Finance UK
How analysts rate Lucid Diagnostics Inc. stock todayShare Buyback & Consistent Profit Alerts - ulpravda.ru
Lucid Diagnostics Inc (LUCD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.13%
자본화:
|
볼륨(24시간):